ArticleHaematologica2024

Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.

David Baden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.